Aktis Oncology is a biotechnology company focused on discovering and developing transformative therapies for solid cancers using alpha radiotherapy.

Aktis Oncology

Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. 

Bristol-Myers Squibb

EcoR1 Capital

Novartis

Octagon Capital Advisors

TCG Crossover

Vida Ventures

MPM Capital

Cowen Healthcare Investments

NS Investment

Merck

Mirae Asset Venture Investment

MRL Ventures Fund

Aktis Oncology is pleased to announce our participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. Matthew Roden, CEO, will be presenting on September 4th from 10:00 to 10:35 a.m. at the New York Marriott Marquis. 
  
We look forward to sharing our vision for the future of oncology and connecting with industry leaders and investors. 
 
https://lnkd.in/gxU8ZsCq

Today, we celebrate Women's Equality Day and honor the incredible contributions women have made to cancer research and treatment.
 
From Marie Curie's groundbreaking work on radioactivity to Dr. Jane Cooke Wright's pioneering chemotherapy research, women have been at the forefront of oncology breakthroughs for generations. 
 
At Aktis Oncology, we're proud to have talented women driving our mission forward. We remain committed to fostering an inclusive environment where all voices are heard and valued.

#WomensEqualityDay #WomeninSTEM #CancerResearch #JoinUs

At Aktis Oncology, we believe in supporting our community. On Child Protection Day, our team volunteered with GIVING FACTORY DIRECT by Cradles to Crayons to address clothing insecurity affecting 22 million American children.
 
Aktis Oncology proudly matched each donation. 
 
#ChildProtectionDay #GivingBack #cradlestocrayons

Today we are proud to announce the promotions of four exceptional people within our organization. Join us in congratulating:

·  Will Blackwell on his promotion to Director, Chemistry
·  Tatsiana Kosciuk on her promotion to Senior Scientist, Molecular Pharmacology
·  Marci Copeland on her promotion to Principal Scientist, Molecular Pharmacology
·  Wai Lau on his promotion to Director, Lead Discovery
 
We are proud to have such talented individuals as part of our team and look forward to their continued achievements in their new roles. Please join us in celebrating their well-deserved success!
 
#AktisOncology #GreatPlaceToWorkFor #GreatCompanyCulture #Collaboration #Innovation #Growth #Hiring

Celebrating PRIDE together!  
  
Our teams in Boston and RTP recently gathered for a special PRIDE luncheon. We proudly supported LGBTQ+ owned businesses, Basil Tree and Indulge Catering, who provided delicious food for the event. 
  
Thank you to all our employees who joined in this celebration. Together, we support an inclusive workplace for all. 
  
#PrideMonth #Inclusion #LGBTQAllies

In celebration of Asian America and Pacific Islander Heritage Month, we embraced the rich cultures of the Pacific Islands by offering hula lessons for our employees! 
  
It was amazing to see our team members learn the movements and meaningful traditions behind this beautiful Hawaiian dance. The lessons highlighted the storytelling and spiritual aspects of hula. Big mahalo to our Aktis hula instructor, Kelly Williamson Polanco, who was happy to share a part of her family heritage.
  
At Aktis Oncology, we take pride in recognizing the diverse backgrounds and perspectives of our team. Initiatives like this help create a more inclusive workplace where we can learn from each other and have fun. 
  
#AAPIHeritageMonth #DiversityCelebration #EmployeeEngagement #HulaDance

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 1, 2024 12:25 AM	c39e7247
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	b43cf33c
crunchbase profile	general
li profile	general	Sep 1, 2024 12:25 AM	0f824719
translate crunchbase fundingrounds	general
peers	general	Sep 1, 2024 12:25 AM	73d15dc6
news basic	general	Sep 1, 2024 12:25 AM	e04abb42
bundesanzeiger	filings
financials download nd	financials
private financials	financials

AKTI

COM:AKTISONCOLOGY

Aktis Oncology